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RecoveryThis study aimed to explore the role of C-reactive protein (CRP) in mediating the association between
greater pre-operative depression symptoms and longer post-operative length of stay in patients under-
going coronary artery bypass graft (CABG) surgery. We used a sample of 145 elective CABG patients
and measured depression symptoms using the Beck Depression Inventory (BDI) prior to surgery and col-
lected baseline measures of CRP. Participants were followed up during their in-hospital stay to measure
early (1–3 days post-surgery) and persistent (4–8 days post-surgery) CRP responses to surgery. We found
that compared with participants with low depression symptoms, those with elevated depression symp-
toms (BDI > 10) prior to CABG were at increased odds of a hospital stay of greater than one week (OR 3.51,
95% CI 1.415–8.693, p = 0.007) and that greater persistent CRP responses mediated this association. Fur-
ther work is needed to explore the exact physiological pathways through which depression and CRP
interact to affect recovery in CABG patients.
 2013 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Depression is commonly experienced by patients undergoing
coronary artery bypass graft (CABG) surgery (Blumenthal et al.,
2003; Burg et al., 2003a; Oxlad and Wade, 2006; Pirraglia et al.,
1999; Tully et al., 2008). Patients with pre-operative depression
have been found to experience a host of poorer surgical recovery
outcomes (Burg et al., 2003a) including longer post-operative hos-
pital stays (Oxlad et al., 2006). Post-operative stay is a proxy mea-
sure of acute physical recovery as well as being an important
indicator of recovery in the longer-term, as it has been found to
be associated with hospital readmission (Hannan et al., 2003)
and recurrent cardiac events (Connerney et al., 2001). Many clini-
cal risk factors are established predictors of prolonged length of
stay (Tu et al., 1995), though little attention has been paid to the
role of inﬂammation.
Pre-operative C-reactive protein (CRP) levels have been shown
to predict adverse outcomes in CABG patients (De Lorenzo et al.,
2012), with results showing that those with elevated pre-operative
CRP (P3 mg/l) had signiﬁcantly greater risk of post-operative mor-
tality. Elevated pre-operative CRP has also been shown to be asso-
ciated with longer hospital stays after CABG (Perry et al., 2010).
CABG surgery itself is associated with an acute inﬂammatory re-sponse and while the extent of the inﬂammatory response is
thought largely to reﬂect the amount of trauma derived from the
surgical procedure itself, it is associated with a host of clinical out-
comes, both cardiac and non-cardiac in scope (Biglioli et al., 2003;
Levy and Tanaka, 2003). An observational study of 29 cardiopulmo-
nary bypass patients by Holmes and colleagues (Holmes et al.,
2002) used a median split to compare outcomes between those pa-
tients who showed a heightened inﬂammatory response at four
hours post-CABG, to those who did not. Findings showed that hy-
per-responders in interleukin (IL)-8, IL-6 and complement recep-
tor-3 had greater risk of adverse clinical outcomes. Therefore,
greater pre- and post-operative inﬂammatory markers have both
been associated with poorer recovery following CABG surgery.
Depression is associated with an innate inﬂammatory response
(Raison et al., 2006), and a meta-analysis by Howren and
colleagues has shown depressive symptoms to be positively
associated with CRP, IL-1 and IL-6 in both clinical and community
samples (Howren et al., 2009). A more recent meta-analysis by
Dowlati and colleagues (Dowlati et al., 2010) has supported the
role of pro-inﬂammatory markers in depression, in particular IL-6
and tumor necrosis factor (TNF)-a. Epidemiological evidence for
the directionality of the depression–inﬂammation relationship is
mixed, with some studies suggesting that depression precedes
inﬂammation (Stewart et al., 2009), while others show that inﬂam-
mation precedes depression (Gimeno et al., 2008). Many investiga-
tors argue that there is a bidirectional association between
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Matthews et al., 2010).
Only one study to date has assessed the association between
depression and inﬂammation in CABG patients (Yang et al., 2012).
These authors studied 232 patients undergoing CABG surgery and
found that higher pre-operative high sensitivity (hs)-CRP was pre-
dictive of depression symptoms up to sixmonths following surgery,
after controlling for covariates. However, little is known about the
direction of the causal relationship between depression and CRP
for predicting CABG recovery. The aim of this study was to prospec-
tively assess the relationship between pre-operative depression
symptoms and length of post-operative stay, and to examine the
extent to which any association could be moderated by inﬂamma-
tion both pre- and post-surgery. Speciﬁcally, we hypothesised that
greater depression symptoms would be associated with longer hos-
pital stays, and that the effect of depression symptoms on length of
stay would be mediated by in-hospital hs-CRP.2. Methods
2.1. Participants
The study uses data collected in the Adjustment and Recovery
after Cardiac Surgery (ARCS) Study. The recruitment and retention
of participants into the ARCS Study is displayed in Fig. 1. Brieﬂy,
347 patients were recruited to the study, and pre-surgery blood
samples were obtained from a subsample of 260 participants
(see Fig. 1). Participants included in these analyses were the 145
CABG surgery patients (mean age: 67.49 ± 9.09 years, 10.3% fe-
males) with complete data for all variables at baseline and fol-
low-up, including covariates. Compared with the participants
who were included in these analyses (N = 145), the participants
who had missing follow-up blood data and missing questionnaire
data (N = 115) were more likely to have had a greater number of
grafts (t = 2.65, p = 0.009) and a lower EuroSCORE (t = 2.02,
p = 0.045), but otherwise did not differ on any other clinical or
demographic variable. Participants were consecutively recruited
from a pre-surgery assessment clinic at St. George’s Hospital, Lon-
don. The baseline assessment took place on average 31 days before
patients’ surgery when they came to the hospital for their pre-
assessment clinic appointment. Inclusion criteria permitted only
patients who were undergoing elective CABG surgery or CABG plus
valve replacement to participate. CABG surgery was deﬁned to in-
clude both on-pump and off-pump surgical procedures. In addi-
tion, participants had to be able to complete the questionnaires
in English, and be 18 years or older. Participants who were too un-
well to participate or who were physically impaired (e.g. visual
impairment) were excluded, based on the advice of the pre-assess-
ment clinic nurses. However, we did not speciﬁcally exclude par-
ticipants because of concurrent mental or physical illness. All
procedures were carried out with the written consent of the partic-
ipants. Ethical approval was obtained from the South West London
research ethics committee.2.2. Measures
2.2.1. Predictor: depression symptoms
The Beck Depression Inventory (BDI) (Beck et al., 1988) was
used to measure depression symptoms at baseline. It is a 21-item
questionnaire which asks the respondent to reﬂect on how they
have been feeling over the past 2 weeks. Ratings were summed,
with higher scores indicating greater emotional disturbance, with
a range of 0–63 (Cronbach’s a = 0.85). A binary variable was gener-
ated according to accepted cut-offs: a score of 0–10 indicating no
depression and 11–63 suggesting mild to severe depression.2.2.2. Mediator: hs-CRP immunoassays
To assess inﬂammatory activity, a 20 mL blood sample was
drawn into a serum separator tube by venepuncture from the
forearm at baseline. During the post-operative in-hospital stay,
blood samples were drawn on approximately day 1 and 4 after
surgery. Due to the variability in collection day for the post-oper-
ative bloods, two summary scores were created. The ﬁrst sum-
mary score used the mean for the hs-CRP values on days 1, 2
and 3 post-surgery and the second used the mean for the hs-
CRP values on days 4, 5, 6, 7 and 8 post-surgery. These scores
were termed ‘early’ and ‘persistent’ responses. Blood was allowed
to clot and centrifuged for 10 min at 3000 rpm. The resulting ser-
um was frozen at 80 C until batch analysis at a later date. As-
says were performed by Dr. David Gaze at St. George’s Healthcare
NHS Trust, using commercial automated immunoassay on the
Immulite 1 (Siemens Healthcare Diagnostics, Frimley, Surrey).
The minimal detectable dose was 0.01 mg/dL, the upper limit of
detection was 15 mg/dL and the intra-assay CV range was 4.2–
6.4%.2.2.3. Outcome: length of stay
Length of post-operative hospital stay was collected from clini-
cal records. Length of stay is a proxy marker of clinical recovery,
with those participants experiencing the poorest recovery and
the greatest in-hospital complications, expected to have the lon-
gest hospital stays after CABG. The policy at the hospital during
this period was to discharge patients within 7 days of CABG pro-
viding there were no complications, and this policy remained in
force throughout the period of data collection.2.2.4. Covariates: cognitive, clinical and sociodemographic measures
The Montreal Cognitive Assessment (MoCA) (Nasreddine et al.,
2005) was administered at baseline. It was developed as a brief
measure of mild cognitive impairment covering eight cognitive do-
mains: visuospatial awareness, executive functioning, short-term
memory, attention, concentration, working memory, language
and orientation to time and place. A maximum of 31 points was
awarded, including an extra point being awarded to participants
with 612 years of education.
Cardiovascular history, clinical factors during admission and
management were obtained from clinical notes. Clinical risk was
assessed using the European System for Cardiac Operative Risk
Evaluation (EuroSCORE) (Roques et al., 2003). EuroSCORE is a com-
posite measure of procedural mortality risk based on 17 factors
comprising patient-related factors (e.g. age, sex), cardiac-related
factors (e.g. unstable angina, recent MI) and surgery-related factors
(e.g. surgery on thoracic aorta). Items were scored in accordance
with the ‘logistic EuroSCORE’ method to generate a percentage
mortality risk estimate; further details of the scoring method can
be found on the EuroSCORE website (www.euroscore.org/logistic-
EuroSCORE.htm). In addition, the number of grafts a participant re-
ceived and whether they underwent cardiopulmonary bypass (yes/
no) were also recorded. History of diabetes was taken frommedical
notes, with participants being categorised according to their treat-
ment status: none, diet, oral hypoglycaemic drugs or insulin. Par-
ticipants were asked to report any longstanding illnesses prior to
surgery; responses were counted to compute a chronic illness bur-
den variable to capture the number of illnesses a participant had in
addition to their coronary artery disease. Prescribed medication
use was recorded, including use of antidepressants and statins.
Smoking was measured as a binary variable (current smoker/
non-smoker). Body mass index (BMI) was assessed at the pre-oper-
ative clinic appointment and calculated using the standard formula
(kg/m2).
ENROLLMENT 
FOLLOW-UP
ANALYSIS
Assessed for eligibility
(n = 572)
Excluded
• Too unwell/physically impaired 
(n=10)
• Declined to participate (n = 
118)
Consented
(n = 444)
BASELINE
Analysed
(n = 145)
Excluded
• Mortality prior to surgery (n = 
3)
• Failed to complete baseline 
questionnaire (n = 56 )
• Removed from surgery 
list/change in surgery 
procedure (n = 38)
Valid baseline 
assessments
(n = 347)
Excluded
• Missing questionnaire data (n = 
13)
Excluded
• In-hospital mortality post-
surgery (n = 2)
• Post-operative blood failed to be 
collected (n = 100)
Baseline blood drawn
(n = 260)
Post-operative blood 
drawn and hospital 
discharge information 
available
(n = 158)
Fig. 1. Flow diagram of participant recruitment and attrition.
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Associations between variables were assessed using Pearson’s
correlations for continuous data and t-tests and chi-square tests
for categorical variables. To test the association between baseline
depression and length of hospital stay, we analysed baseline
depression as a binary variable using the BDI standard cut-off of
10, and modelled associations between pre-operative depression
and post-operative length of stay using logistic regressions. Since
data on length of post-operative hospital stay were skewed, a bin-
ary cut-off of 7 days was implemented. This approach was deemed
appropriate given it is a clinically pertinent indicator of recovery,
with St. George’s Hospital guidelines aiming for all patients to be
discharged within 7 days of CABG surgery. Linear regressions were
performed using the continuous BDI scores to corroborate the ﬁnd-
ings found with the binary BDI variable; due to the length of stay
data being skewed, this variable was log-n transformed prior touse in these models. We have chosen to use the results using the
binary outcomes as the primary analyses here since they are more
clinically meaningful. We included covariates that might poten-
tially relate to the outcomes including: age, sex, BMI, smoking sta-
tus, diabetes status, cardiopulmonary bypass, number of grafts,
chronic illness burden, use of antidepressant medication, Euro-
SCORE and cognitive function (MoCA). Since age and sex and CABG
in isolation are included in EuroSCORE, these covariates are not
included in the fully adjusted models so as to avoid double adjust-
ment. Results are presented as adjusted odds ratios with 95%
conﬁdence intervals (CI). Models adjusting for use of statin medica-
tions were also performed, but are not reported here since the re-
sults did not change; statin records were missing for 9 participants.
We tested the association between hs-CRP and length of stay
using logistic regression models. Post-operative hs-CRP responses
to surgery were modelled as change scores, subtracting the
baseline hs-CRP value from the post-operative value (for both the
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greater response from baseline to follow-up. There were 44 partic-
ipants with missing early hs-CRP samples so the N in these analy-
ses is 101. Baseline hs-CRP was also included in the models as a
separate covariate to assess the relative contribution of both pre-
and post-operative hs-CRP values on length of stay. Separate mod-
els were also performed on baseline hs-CRP to predict length of
stay. Additional adjustments were made for age, sex, BMI, smoking
status, diabetes status, cardiopulmonary bypass, number of grafts,
EuroSCORE, chronic illness burden, use of antidepressant medica-
tion, and MoCA, and are presented as adjusted odds ratios with
95% CI. Again, since age and sex and CABG in isolation are included
in EuroSCORE, they were not included in fully adjusted models.
The association between depression and hs-CRP was assessed
using both t-tests and linear regression models. Finally, in order
to directly test mediation, the Sobel test was implemented, using
the method set out by Preacher and Hayes (2008, 2004). This meth-
od examines the mediation of the predictor and outcome variables,
and tests the signiﬁcance of the indirect effect in the model. The
bootstrapping technique advocated in this method was also
employed. The model included baseline binary BDI score as the
independent variable and binary length of stay as the dependent
variable, with hs-CRP persistent change entered as the mediator.
Covariates included BMI, smoking status, diabetes status, cardio-
pulmonary bypass, number of grafts, EuroSCORE, chronic illness
burden, antidepressant use, MoCA, and baseline hs-CRP. All analy-
ses were conducted using SPSS version 21.3. Results
Table 1 summarises the characteristics of the participants at
baseline, prior to CABG surgery. The sample had an age rangeTable 1
Demographic, clinical and depression characteristics of the sample at baseline
(N = 145).
Characteristic Mean ± SD or N (%)
Age (years) 67.49 ± 9.09
Female 15 (10.3)
BMI (kg/m2) 28.99 ± 4.24
Smoker 13 (9.0)
Statin medication 120 (88.2)*
Antidepressant medication 10 (6.9)
Cognitive function (MoCA) 25.39 ± 3.64
Co-morbidities
Chronic illness burden 0.48 ± 0.71
Diabetes 35 (24.1)
Hypertension 119 (82.1)
Pulmonary disease 10 (6.9)
Neurological disorder 11 (7.6)
Extracardiac arteriopathy 13 (9.0)
Clinical factors
Logistic EuroSCORE (%) 4.21 ± 2.79
CABG in isolation 113 (77.9)
Number of grafts 3.12 ± 1.14
On-pump 112 (77.2)
Baseline hs-CRP (mg/dL) 8.46 ± 9.46
Follow-up ‘early’ hs-CRP (mg/dL) 82.39 ± 58.07**
Follow-up ‘persistent’ hs-CRP (mg/dL) 65.86 ± 59.45
Length of post-operative hospital stay
67 days 100 (69.0)
>7 days 45 (31.0)
Depression symptoms
Total BDI score 9.13 ± 7.04
Depression binary
None (0–10) 100 (69.0)
Mild to Severe (11–63) 45 (31.0)
* N = 136.
** N = 101.between 45 and 87 years, was predominantly male (89.7%) and
overweight (BMI > 25 = 83.4%). The majority of participants were
hypertensive, and approximately a quarter of patients were dia-
betic. The majority of participants had on-pump cardiopulmonary
bypass surgery in isolation. The mean length of post-operative
hospital stay was 8 days, with a range of 4–66 days. The majority
of participants were within the normal range for depression symp-
toms on the BDI, however 45 (31.0%) participants scored >10 at
baseline. Depression symptoms (BDI > 10) were associated with
younger age (t(143) = 3.96, p < 0.001) and smoking (x2 = 6.21,
p = 0.013). No associations were found between BDI scores and
use of statin or antidepressant medication. Longer hospital stays
were associated with smoking (x2 = 6.21, p = 0.013), use of antide-
pressant medication (x2 = 7.62, p = 0.006), and CABG in isolation
(x2 = 15.41, p < 0.001). As shown in Table 2 46.7% of patients with
elevated BDI scores had hospital stays of 7 days or longer, com-
pared with 24.0% of patients with no depression symptoms
(x2 = 7.45, p = 0.006). Using the 45 participants with elevated
depression symptoms (BDI > 10), we compared those with stays
of 7 days or less with those with stays of 7 days or more. Results
showed that the depressed extended stay participants were more
likely to be on antidepressants than the depressed non-extended
stay participants (x2 = 5.02, p = 0.025). While only 4 participants
were using antidepressants in our depressed group, all of them
were in the extended stay group. However, the mean BDI values
did not signiﬁcantly differ between the two groups (t(43) =
1.60, p = 0.117).3.1. The association between depression symptoms and hs-CRP and
length of stay
Table 3 shows the results from two separate logistic regression
models predicting length of post-CABG stay. Model 1 shows that
compared with the no depression symptoms group, patients in
the mild to severe depression group had a 3.5 times greater odds
of a hospital stay of longer than one week (p = 0.007) in fully ad-
justed models. EuroSCORE (odds ratio = 1.24, CI = 1.062–1.437,
p = 0.006) and use of antidepressant medication (odds ra-
tio = 5.60, CI = 1.071–29.290, p = 0.041) were the only other sig-
niﬁcant predictors in the fully adjusted model. Additional
adjustment for use of pre-operative statins did not alter the re-
sults (results not presented here). These results were conﬁrmed
using the continuous BDI scores at baseline (t = 2.19, p = 0.030)
entered into fully adjusted linear regression models to predict
log transformed length of stay. Model 2 in Table 3 presents the
logistic regression results for change in early hs-CRP predicting
length of stay. The results show that for every unit increase in
early hs-CRP change there was a 1.0% increase in the odds of an
extended hospital stay in fully adjusted models (p = 0.030). Use
of antidepressants (odds ratio = 6.26, CI = 1.007–38.884,
p = 0.049) and lower MoCA scores (odds ratio = 0.86, CI = 0.740–
0.995, p = 0.043) were the only other signiﬁcant predictors of
length of stay in this model. Additional adjustment for use of
pre-operative statins did not alter the results (results not pre-
sented here).Table 2
Cross-tabulation of depressed and non-depressed participants by length of stay (LoS).
LoS < 7 days LoS > 7 days Total
BDI 6 10 n 76 24 100
% within 6 10 76.0 24.0 100
BDI > 10 n 24 21 45
% within > 10 53.3 46.7 100.0
Total 100 45 145
Table 3
Depression symptoms and hs-CRP change predicting length of post-operative hospital stay.
Model OR 95% CI p
BDI score
Age and sex adjusted None 1 (Reference) – –
Mild to severe 3.813 1.660–8.760 0.002
Fully adjusted* None 1 (Reference) – –
Mild to severe 3.508 1.415–8.693 0.007
hs-CRP early change (baseline to 1–3 day follow-up)
Age and sex adjusted pg/mL 1.008 1.000–1.016 0.042
Fully adjusted** pg/mL 1.010 1.001–1.020 0.030
hs-CRP persistent change (baseline to 4–8 day follow-up)
Age and sex adjusted pg/mL 1.013 1.006–1.020 <0.001
Fully adjusted** pg/mL 1.013 1.005–1.021 0.002
* Fully adjusted model: smoking status, BMI, diabetes, cardiopulmonary bypass, number of grafts, EuroSCORE, chronic illness burden, antidepressant use and MoCA.
** As fully adjusted model 1, with additional adjustment for baseline hs-CRP.
Table 5
Depression symptoms predicting change in hs-CRP from baseline to the persistent
post-operative period.
Model B SE b p
Smoking status 21.82 17.2 0.11 0.207
BMI 1.41 1.16 0.10 0.228
Number of grafts 9.97 4.28 0.20 0.021
Cardiopulmonary bypass 8.61 11.42 0.06 0.453
Diabetes 0.92 7.02 0.01 0.896
EuroSCORE 5.00 1.76 0.24 0.005
Chronic illness burden 1.94 9.16 0.02 0.832
Antidepressant use 19.37 18.89 0.09 0.307
MoCA 1.85 1.27 0.12 0.149
Baseline hs-CRP 0.80 0.50 0.13 0.110
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change in persistent hs-CRP predicting length of stay. The results
show that for every unit increase in persistent hs-CRP change there
was a 1.3% increase in the odds of an extended hospital stay in fully
adjusted models (p = 0.002). There were no other signiﬁcant pre-
dictors in this model. Again, additional adjustment for use of pre-
operative statins did not alter the results (results not presented
here).
Separate logistic regression models were also performed to as-
sess baseline levels of hs-CRP on length of stay; however, baseline
hs-CRP was found to be a non-signiﬁcant predictor in fully ad-
justed models (odds ratio = 1.00, CI = 0.959–1.042, p = 0.980).Baseline binary BDI 27.00 10.29 0.22 0.010
0
10
20
30
40
50
60
70
80
90
100
Baseline hs-CRP Follow-up early hs-CRP Follow-up persistent hs-CRP
m
g/
dL
BDI ≤10 BDI >10
*
Fig. 2. Change in hs-CRP from pre-operative to post-operative early and post-
operative persistent periods according to BDI status. Bars are standard errors of the
mean. ⁄t = 2.50, p = 0.026.3.2. The association between depression symptoms and pre- and post-
operative CRP
T-Tests were used to demonstrate the difference in hs-CRP lev-
els at baseline and follow-up between depressed and non-de-
pressed participants. These results are displayed in Table 4 and
reveal a signiﬁcant difference according to depression status on
late hs-CRP responses. Linear regression models were performed
to examine the cross-sectional relationship between BDI scores
(t = 0.19, p = 0.851) and hs-CRP levels measured pre-operatively,
with no signiﬁcant association found. Nor was baseline BDI score
(t = 0.03, p = 0.977) associated with change in early hs-CRP re-
sponses. However, in models to predict change in persistent
hs-CRP responses, baseline BDI score (t = 2.62, p = 0.010) was a sig-
niﬁcant predictor in fully adjusted models (see Table 5). The only
other signiﬁcant predictors in this model were EuroSCORE
(t = 2.83, p = 0.005) and a greater number of grafts (t = 2.33,
p = 0.021). The change in hs-CRP over time according to status on
the BDI is illustrated in Fig. 2 showing a similar acute inﬂammatory
response to surgery in both BDI groups; however, the depressed
participants (hsCRP mean = 82.19, standard deviation 75.51 mg/
dL) showed a signiﬁcant continued elevation in hs-CRP in the per-
sistent sample compared to the non-depressed participants (hsCRPTable 4
Differences in hs-CRP responses according to depression status.
hs-CRP (mg/dL) BDI 6 10/>10 N
Baseline Not depressed 100
Depressed 45
1–3 days post-surgery Not depressed 71
Depressed 30
4–8 days post-surgery Not depressed 100
Depressed 45mean = 58.51, standard deviation 49.30 mg/dL) (t = 2.50,
p = 0.026).Mean SD t p
8.17 8.40 0.548 0.585
9.10 11.56
82.81 59.50 0.111 0.912
81.39 55.52
58.51 49.30 2.250 0.026
82.19 75.51
hs-CRP 
persistent 
change
Length of stay 
binary
BDI binary
a b
c’
B = 27.000
p = 0.010
B = 0.002
p = 0.004
B = 0.168
p = 0.042
Fig. 3. Mediation model of baseline BDI score and length of stay through change in
persistent hs-CRP.
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and length of stay
Since baseline BDI scores were not associated with early hs-CRP
change, mediation models were only performed using persistent
hs-CRP change. A Sobel test was used on the data, where pathway
c’ represents the direct effect after controlling for the mediator, and
pathway ab represents the total indirect pathway of the mediator
(see Fig. 3). The indirect pathway was signiﬁcant in this model
(B = 0.05, SE = 0.028, 95% CI = 0.012–0.128), conﬁrming change in
persistent hs-CRP to be a signiﬁcant mediator in this model. Partial
mediation was shown such that the direct effect remained signiﬁ-
cant after persistent hs-CRP change was taken into account.
4. Discussion
In this study we aimed to examine the role of CRP in the rela-
tionship between pre-operative depression and length of post-
operative hospital stay in patients undergoing elective CABG
surgery. We were able to show that patients with elevated depres-
sion symptoms on the BDI were at increased odds of an extended
hospital stay, and that this association was partially mediated by
a greater change in CRP from baseline values to 4–8 days post-sur-
gery. This study is the ﬁrst to our knowledge which has prospec-
tively examined the association between depression and CRP and
their impact on physical recovery in a CABG population.
Our ﬁndings are consistent with previous researchwhich has re-
ported on the prevalence of depression symptoms prior to CABG
surgery. In our sample, one third of participants had elevated scores
on the BDI pre-operatively. Estimates of depression rates before
CABG surgery have varied from between 14.3% and 43.1% (Blumen-
thal et al., 2003; Burg et al., 2003a; Oxlad andWade, 2006; Pirraglia
et al., 1999; Tully et al., 2008). The variability in these estimates are
likely attributable to differences in the measurement of depression
symptoms (e.g. questionnaire or clinical interview), different cut-
off scores being implemented on questionnaire measures, differ-
ences in the timing of depression measurement in relation to
surgery and clinical and demographic differences between samples.
Other studies have examined the detrimental effect of pre-
operative depression for post-CABG surgical recovery. Burg and
colleagues (Burg et al., 2003a) found that patients who were de-
pressed pre-surgery had higher levels of medical complications
during the six months following surgery, and were more likely to
report poor quality of life and worse recovery. Moreover, 2 years
after surgery, pre-surgery depression was linked to greater risk of
death (Burg et al., 2003b). The role of depression on length of hos-
pital stay has been previously examined by Oxlad and colleagues
(Oxlad et al., 2006) who reported similar ﬁndings to the associa-
tions presented here, in that greater pre-operative depression
symptoms were associated with longer hospitalisation. Among
the depressed participants, we found only one difference in theclinical and demographic proﬁle between those having extended
stays compared to those discharged within a week of surgery,
namely the extended stay participants were more likely to be tak-
ing antidepressants. However, there was no difference in mean BDI
scores between these groups, which suggests that depression
severity cannot account for the difference in length of stay. We ad-
dressed the possible inﬂuence of antidepressant use by using this
as a covariate in fully adjusted models. Mechanisms underlying
the association between depression and poor surgical recovery
have received little attention previously.
Pre-operative CRP has been associated with poorer outcomes in
CABG surgery patients, however the role of post-operative surgical
responses has been less well studied. In our analyses we were able
to show that change in CRP responses from pre-CABG to measures
taken in the early and persistent post-operative phases were asso-
ciated with increased odds of an extended length of stay. However,
pre-operative measures of hs-CRP were not associated with length
of stay. Our results are in line with a study of 29 participants by
Holmes and colleagues (Holmes et al., 2002) who found that those
with the largest inﬂammatory response 4 h post-CABG were at
greatest risk of adverse clinical outcomes. More work is needed
to tease apart these temporal effects of CRP in greater detail using
larger samples and a variety of physical recovery endpoints. In
addition, since length of stay is a marker of short-term recovery,
future work is needed to address whether the same effects will
be borne out in the longer term.
Our results show that while baseline levels of CRP were unre-
lated to depressive symptoms, at the post-surgery assessment a
discrepancy occurred with depressed participants failing to return
to basal levels at the same rate as non-depressed participants. This
result suggests that depression symptoms moderate the body’s
ability to self-regulate following cardiac surgery. An analogous
ﬁnding was reported by Shaffer and colleagues in a sample of
163 acute coronary syndrome patients (Shaffer et al., 2011). These
authors reported that elevated depression symptoms predicted a
lesser decrease in CRP across the month following the cardiac
event, which the authors describe as reﬂecting a poorer remission
in the underlying inﬂammatory process. Our ﬁndings are the ﬁrst
to our knowledge that have explored this effect in CABG surgery
patients. Our results suggest that pre-operative depression in some
individuals promotes persistent inﬂammation beyond the period
that might be expected by the physical trauma caused by the
surgery itself. This persistent inﬂammation in turn might lead to
phenomena that produce more extended hospital stays, such as
infection or slower wound healing. This hypothesis requires fur-
ther testing using other post-operative recovery endpoints to cor-
roborate our ﬁndings using length of stay.
We have also provided evidence that change in hs-CRP from
baseline to the 4–8 days after surgery partially mediated the rela-
tionship between pre-operative depression and length of post-
CABG hospital stay. Other mechanisms are also likely to play a role
alongside the inﬂammatory pathway. For example, it is possible
that behavioural pathways such as physical activity, diet and med-
ication adherence contribute to the relationship between pre-oper-
ative depression and recovery following CABG surgery, since
previous work has found such factors to be relevant to both
depression and cardiac health (Rieckmann et al., 2011; Whooley
et al., 2008). While smoking and BMI were included in our fully ad-
justed models, further attention should be paid to the role of other
lifestyle factors in future work on CABG patients.
Length of stay is likely to be affected by a variety of clinical and
non-clinical factors and therefore we would emphasise that this
outcomemeasure is only a proxy marker of physical recovery. Nev-
ertheless, the fact that depression negatively impacted length of
stay remains a clinically signiﬁcant result. For example, the cost
of hospital stays for CABG surgery have been estimated to be
L. Poole et al. / Brain, Behavior, and Immunity 37 (2014) 115–121 121approximately £1500 for every day spent in intensive care (The
Lancet, 2010) and £264 for every day spent on the general ward
(Department of Health, 2012). In the ARCS study the surgery was
carried out in a public hospital, where issues such as insurance
cover and cost do not inﬂuence length of stay.
There are several strengths to our study. The longitudinal
design of the ARCS study allows for the temporal relationship be-
tween depression, CRP and length of stay to be analysed. Moreover,
the repeated assessment of CRP has allowed us to test the contri-
bution of pre-operative and post-operative inﬂammation. In addi-
tion, the ARCS study examined patients undergoing CABG at a
single hospital and therefore removes the inﬂuence of inter-hospi-
tal variation in discharge policy. However, there are also a number
of limitations. Firstly, we have relied on a questionnaire measure of
depression symptoms, which restricts us from generalising our re-
sults to clinically depressed samples. Secondly, while we have used
length of stay as a proxy measure of physical recovery in the sam-
ple, we must also acknowledge that other, non-medical, factors are
also likely to play a role in determining length of stay such as social
housing constraints; such confounders were not able to be taken
into account in our analyses. Lastly, there was a preponderance
of male participants in the ARCS study with 10.3% of the sample
being female. This male majority is characteristic of the CABG sur-
gical population more generally, with men more likely to receive a
revascularisation procedure than women in the UK. For example, in
the ARCS study 444 patients were invited to participate, out of
these only 66 patients (14.9%) were female. Therefore, the total
number of women included in these analyses only slightly under-
represents the targeted clinical population. However, we included
sex in all analyses as a covariate in order to address this issue. The
ﬁndings we have reported have clinical implications regarding the
treatment and screening of depression in a CABG population. How-
ever, more work is needed in order to investigate the best ways to
approach the treatment of depression in this patient group.
In conclusion, we have found that pre-operative depression
symptoms were associated with longer post-operative hospital
stays in patients undergoing CABG surgery, and that this associa-
tion was mediated by changes in CRP from pre-operative to post-
surgery levels. Further work is needed in order to understand the
processes through which depression and CRP interact to affect car-
diac recovery.
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